InvestorsHub Logo
Followers 11
Posts 1101
Boards Moderated 0
Alias Born 11/21/2016

Re: Curecovid post# 15090

Friday, 08/21/2020 8:15:40 AM

Friday, August 21, 2020 8:15:40 AM

Post# of 42623
Thanks. Just read through it real quick.

Thought this was interesting. Look at how they labeled the ticker.


The only treatment options in contention for a quick approval are Humanigen (NASDAQ : HGEN) lenzilumab which just got approval to roll out its Phase 3 study in Brazil.